These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 34795827)

  • 1. Drivers of the third wave of COVID-19 in Zimbabwe and challenges for control: perspectives and recommendations.
    Murewanhema G; Mutsigiri-Murewanhema F
    Pan Afr Med J; 2021; 40():46. PubMed ID: 34795827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of increased mobility on SARS-CoV-2 transmission: a descriptive study of the trends of COVID-19 in Zimbabwe between December 2020 and January 2021.
    Murewanhema G; Burukai TV; Chiwaka L; Maunganidze F; Munodawafa D; Pote W; Mufunda J
    Pan Afr Med J; 2021; 39():125. PubMed ID: 34527141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 control pitfalls and challenges and drivers of SARS-CoV-2 transmission in Zimbabwe.
    Murewanhema G
    Pan Afr Med J; 2021; 38():28. PubMed ID: 33777296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ranking the relative importance of COVID-19 vaccination strategies in Canada: a priority-setting exercise.
    Zhao L; Ismail SJ; Tunis MC
    CMAJ Open; 2021; 9(3):E848-E854. PubMed ID: 34493551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 vaccines and vaccination: how prepared is Africa?
    Ariyo OE; Oladipo EK; Osasona OG; Obe O; Olomojobi F
    Pan Afr Med J; 2021; 39():107. PubMed ID: 34512843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 vaccine hesitancy in South Africa: how can we maximize uptake of COVID-19 vaccines?
    Cooper S; van Rooyen H; Wiysonge CS
    Expert Rev Vaccines; 2021 Aug; 20(8):921-933. PubMed ID: 34252336
    [No Abstract]   [Full Text] [Related]  

  • 7. Predictors of COVID-19 vaccine hesitancy among Egyptian healthcare workers: a cross-sectional study.
    El-Sokkary RH; El Seifi OS; Hassan HM; Mortada EM; Hashem MK; Gadelrab MRMA; Tash RME
    BMC Infect Dis; 2021 Aug; 21(1):762. PubMed ID: 34353279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination hesitancy among women of reproductive age in resource-challenged settings: a cause for public health concern.
    Murewanhema G
    Pan Afr Med J; 2021; 38():336. PubMed ID: 34285758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 vaccination hesitancy and challenges to mass vaccination.
    Chau CYC
    Hong Kong Med J; 2021 Oct; 27(5):377-379. PubMed ID: 34657836
    [No Abstract]   [Full Text] [Related]  

  • 10. COVID-19 Vaccination Efforts: Is Afghanistan Prepared?
    Wardak MF; Rahimi A; Ahmadi A; Madadi S; Arif S; Nikbin AM; Nazari GA; Azizi AT; Mousavi SH; Lucero-Prisno DE
    Am J Trop Med Hyg; 2021 Aug; 105(5):1137-1140. PubMed ID: 34464328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 and the rise of anti-science.
    Hotez P
    Expert Rev Vaccines; 2021 Mar; 20(3):227-229. PubMed ID: 33599568
    [No Abstract]   [Full Text] [Related]  

  • 12. Dealing with vaccine hesitancy in Africa: the prospective COVID-19 vaccine context.
    Afolabi AA; Ilesanmi OS
    Pan Afr Med J; 2021; 38():3. PubMed ID: 33520072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zimbabwe's vaccination momentum needs an 'urgent boost' ahead of an imminent COVID-19 resurgence.
    Murewanhema G; Dzinamarira T; Mapingure M; Chingombe I; Mukwenha S; Musuka G; Madziva R; Herrera H
    S Afr Med J; 2021 Dec; 111(12):1164-1165. PubMed ID: 34949300
    [No Abstract]   [Full Text] [Related]  

  • 14. The COVID-19 pandemic and its implications for cervical cancer treatment and prevention in Zimbabwe: perspectives and recommendations.
    Murewanhema G
    Pan Afr Med J; 2021; 39():149. PubMed ID: 34527165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How can a global pandemic affect vaccine hesitancy?
    Dubé E; MacDonald NE
    Expert Rev Vaccines; 2020 Oct; 19(10):899-901. PubMed ID: 32945213
    [No Abstract]   [Full Text] [Related]  

  • 16. Vaccine hesitancy and other obstacles to COVID-19 control: lessons from smallpox.
    Davis R
    Pan Afr Med J; 2021; 40():1. PubMed ID: 34650651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidance for Implementing COVID-19 Prevention Strategies in the Context of Varying Community Transmission Levels and Vaccination Coverage.
    Christie A; Brooks JT; Hicks LA; Sauber-Schatz EK; Yoder JS; Honein MA;
    MMWR Morb Mortal Wkly Rep; 2021 Jul; 70(30):1044-1047. PubMed ID: 34324480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. With Great Hopes Come Great Expectations: Access and Adoption Issues Associated With COVID-19 Vaccines.
    Su Z; McDonnell D; Cheshmehzangi A; Li X; Maestro D; Šegalo S; Ahmad J; Hao X
    JMIR Public Health Surveill; 2021 Aug; 7(8):e26111. PubMed ID: 33560997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Looming Threat Within a Pandemic: Vaccine Hesitancy and Refusal.
    O'Malley PA
    Clin Nurse Spec; 2021; 35(1):11-13. PubMed ID: 33259356
    [No Abstract]   [Full Text] [Related]  

  • 20. The Persistence of Vaccine Hesitancy: COVID-19 Vaccination Intention in New Zealand.
    Thaker J
    J Health Commun; 2021 Feb; 26(2):104-111. PubMed ID: 33719898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.